Sage Journals: Discover world-class research

Free access

Research article

First published 2017-7

Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer

Praveenkumar Shetty, Vidya S Patil, Rajashekar Mohan [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Retricted access

Research article

First published 2012-3

The prognostic value of triple negative in stage II/III breast cancer

Afaf T Elnashar, El-Sayed M Ali, Ahmed Gaber

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2018

The Effect of Perioperative Bevacizumab on Disease-Free and Overall Survival in Locally Advanced HER-2 Negative Breast Cancer: A Meta-Analysis

Yanal Alnimer, Zakaria Hindi, Khalil Katato

Breast Cancer: Basic and Clinical Research

Free access

Review article

First published 2023-04-20

Efficacy and safety of antibody-drug conjugates in triple-negative and HER-2 positive breast cancer: A systematic review and meta-analysis of clinical trials

Fatima Afzal, Wajeeha Aiman, Hafsa Zahoor [...]

Breast Disease

Retricted access

Research article

First published 2020-07

Integrated Analysis of mRNA–miRNA–lncRNA ceRNA Network in Human HR+/Her-2− Breast Cancer and Triple Negative Breast Cancer

Xiaochen Jia, Yehui Shi, Yuehong Zhu [...]

Journal of Computational Biology

Open access

Research article

First published 2024

Her Lips Are Sealed: Effects of Negative Feedback on Women’s Participation in Online Political Discussions

Zhaodi Chen, Junghun Han

Socius: Sociological Research for a Dynamic World

Open access

Review article

First published 2013

Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?

Walter P. Carney, Dirk Bernhardt, Bharat Jasani

Biomarkers in Cancer

Retricted access

Review article

First published 2024-12

Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive,HER-2-Negative Metastatic Breast Cancer

Alexa J. Luboff, David L. DeRemer

Annals of Pharmacotherapy

Open access

Research article

First published 2020-1

HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy

Georgios Moustakas, Spyridon Kampantais, Anastasia Nikolaidou [...]

Journal of International Medical Research

Open access

Research article

First published 2019

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer,including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial

Giuseppe Gullo, Alex J. Eustace, Alexandra Canonici [...]

Therapeutic Advances in Medical Oncology

Search results